Filtered By:
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 5132 results found since Jan 2013.
Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study
CONCLUSION: The role of INCS in COVID-19 is still unclear, but exposure to INCS does not adversely affect COVID-19 mortality. Further studies are needed to explore the association between their use and inflammatory activation, viral load, ACE2 gene expression, and outcomes, exploring different types and doses of INCS.PMID:37414336 | DOI:10.1016/j.anai.2023.06.026
Source: Annals of Allergy, Asthma and Immunology - July 6, 2023 Category: Allergy & Immunology Authors: Dr Virginia Hernandez Santiago Dr Adeniyi Francis Fagbamigbe Prof Frank Sullivan Dr Utkarsh Agrawal Dr Daniel Morales Prof Colin McCowan Prof Brian Lipworth Source Type: research
The Conspirituality of Robert F. Kennedy Jr.
This article has been adapted from Chapter 23 of Conspirituality: How New Age Conspiracy Theories Became a Health Threat by Derek Beres, Matthew Remski, and Julian Walker. Copyright © 2023. Available from PublicAffairs, an imprint of Hachette Book Group, Inc.
Source: TIME: Health - July 5, 2023 Category: Consumer Health News Authors: Derek Beres, Matthew Remski, and Julian Walker Tags: Uncategorized freelance politics Source Type: news
Establishing a Virtual Home Assessment Program: from Concept to Implementation as a Result of the COVID-19 Pandemic
This article describes the development and delivery process, timelines of caregiver interaction, and guidelines for performing virtual home assessments. It summarizes the challenges and benefits of using a virtual process for delivering home assessment services for asthma and allergy patients. Overall, caregivers indicated they found the use of virtual technology had significant benefits for them including their personal comfort and the time efficiency gained by using virtual visits to interact with Healthy Homes Program staff.
Source: Current Allergy and Asthma Reports - July 5, 2023 Category: Allergy & Immunology Source Type: research
Eosinophil-independent IL-5 levels are increased in critically ill COVID-19 patients who survive
Source: Allergy, Asthma and Clinical Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Xiaotian Ju, Kiho Son, Rameen Jamil, Sarah Culgin, Brittany Salter, Kate Miyasaki, Nahal Emami Fard, Maria Xiao, Zil Patel, Kayla Zhang, Braeden Cowbrough, Melanie Kjarsgaard, Katherine Radford, Anna Dvorkin-Gheva, Carl D. Richards, Gerard Cox & hellip; Tags: Letter to the editor Source Type: research
Prevention and Treatment of COVID-19-Associated Mucormycosis
AbstractPurpose of reviewThe present article will describe the unique factors present in COVID-19 patients that predispose these individuals to develop mucormycosis with emphasis placed on the prevention and treatment of COVID-19-associated mucormycosis (CAM).Recent findingsViral specific factors, pre-existing diabetes mellitus, and COVID-19 treatments combine to facilitate the development of mucormycosis. There appears to be a gross overutilization of steroid and antibiotic therapy among COVID-19 patients. Appropriate stewardship of antibiotic and steroid therapy in conjunction with tight glucose control may prevent the d...
Source: Current Treatment Options in Allergy - July 4, 2023 Category: Allergy & Immunology Source Type: research
Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study
Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute COVID-19, however little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.
Source: Annals of Allergy, Asthma and Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe, Prof Frank Sullivan, Dr Utkarsh Agrawal, Dr Daniel Morales, Prof Colin McCowan, Prof Brian Lipworth Tags: Original Article Source Type: research
Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD
Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute coronavirus disease 2019 (COVID-19); however, little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.
Source: Annals of Allergy, Asthma and Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Virginia Hernandez Santiago, Adeniyi Francis Fagbamigbe, Frank M Sullivan, Utkarsh Agrawal, Daniel Morales, Colin McCowan, Brian Lipworth Tags: Original Article Source Type: research
During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant
AbstractThe most severe forms of COVID-19 share many features with bacterial sepsis and have thus been considered to be a viral sepsis. Innate immunity and inflammation are closely linked. While the immune response aims to get rid of the infectious agent, the pro-inflammatory host response can result in organ injury including acute respiratory distress syndrome. On its side, a compensatory anti-inflammatory response, aimed to dampen the inflammatory reaction, can lead to immunosuppression. Whether these two key events of the host inflammatory response are consecutive or concomitant has been regularly depicted in schemes. I...
Source: Clinical Reviews in Allergy and Immunology - July 3, 2023 Category: Allergy & Immunology Source Type: research
Immune-based Therapies —What the Emergency Physician Needs to Know
This article provides a review of the mechanisms of action, indications for use, and potential complications of immunotherapy treatments that are relevant in the emergency care setting.
Source: Immunology and Allergy Clinics of North America - July 1, 2023 Category: Allergy & Immunology Authors: Sarah B. Dubbs, Cheyenne Falat, Lauren Rosenblatt Source Type: research
Adverse events following immunisation (AEFI) of COVISHIELD vaccination among healthcare workers in Ghana
Conclusion
The results of our study indicate a high incidence of non-serious AEFI and the rare occurrence of serious AEFI after COVISHIELD vaccination in healthcare workers. The rate of AEFI was higher after the first dose than after the second dose. Sex, age, previous SARS-CoV-2 infection, allergies and comorbidity were not significantly associated with the onset and duration of AEFI.
Source: BMJ Open - June 28, 2023 Category: General Medicine Authors: Marfoh, K., Samba, A., Okyere, E., Acheampong, F., Owusu, E., Darko, D. N. A., Zakariah, J., Mensa, H., Aidoo, E., Mohammed, Y. Tags: Open access, Immunology (including allergy), COVID-19 Source Type: research
Anthony Fauci to Join Georgetown University Faculty
Anthony Fauci led the National Institute of Allergy and Infectious Diseases for nearly four decades under seven presidents. Anthony Fauci , the government’s longtime top infectious-disease expert known for guiding the nation through the Covid-19 pandemic, is joining the faculty at Georgetown…#anthonyfauci #georgetownuniversity
Source: Reuters: Health - June 26, 2023 Category: Consumer Health News Source Type: news
COVID-19, Coronavirus Vaccines, and Possible Association with Lipsch ütz Vulvar Ulcer: A Systematic Review
In conclusion, COVID-19 and immunization against SARS-CoV-2 add to Epstein-Barr virus as plausible triggers of Lipschütz genital ulcer.
Source: Clinical Reviews in Allergy and Immunology - June 26, 2023 Category: Allergy & Immunology Source Type: research
Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions
CONCLUSIONS: Considering the potentially life-saving benefits of vaccination in a global pandemic environment, it is a safe and effective method to administer vaccines to at-risk patients using desensitization or split dosing techniques, based on their sensitivity status determined through a PEG skin test. This approach allows for the avoidance of preventing access to vaccines, while still ensuring the safety of patients.PMID:37345399 | DOI:10.5578/tt.20239920
Source: Tuberkuloz ve Toraks - June 22, 2023 Category: Respiratory Medicine Authors: Şeyma Özden Fatma Merve Tepetam Özge Atik Source Type: research
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients
Vaccine. 2023 Jun 15:S0264-410X(23)00714-4. doi: 10.1016/j.vaccine.2023.06.039. Online ahead of print.ABSTRACTBasophil activation test (BAT) can tackle multiple mechanisms underlying acute and delayed hypersensitivity to drugs and vaccines and might complement conventional allergy diagnostics but its role in anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-related hypersensitivity is ill-defined. Therefore, 89 patients with possible hypersensitivity (56 % with delayed mucocutaneous manifestations) to anti-SARS-CoV-2 vaccines were tested with BAT for Macrogol 3350, DMG-PEG 2000, PEG 20000, polysorba...
Source: Vaccine - June 22, 2023 Category: Allergy & Immunology Authors: Patrizia Pignatti Giuseppe Alvise Ramirez Marco Russo Paolo Marraccini Serena Nannipieri Chiara Asperti Fabrizio Della Torre Antonio Tiri Beatrice Maria Gatti Antonella Gurrado Antonio Meriggi Giovanni Benanti Maria Bernadette Cilona Paolo Pigatto Samuele Source Type: research
